Thermo Fisher Scientific Inc (TMO)

NYSE · Health Care · Diagnostics & Research
By Alex · Tickerpine
$603.01
-1.99 (-0.33%)
Price — last 10 years monthly, dividend-adjusted · hover for detail
Market Cap
$222.96B
P/E (TTM)
32.6
Forward P/E
21.9
EPS (TTM)
$18.51
ROE
13.51%
Profit Margin
15.04%
Revenue Growth
10.50%
Dividend Yield
0.31%
Beta
0.85
52W High
$643.99
52W Low
$435.27
Analyst Target
$631.42

TMO stock forecast: what analysts expect

Consensus rating
Buy
Avg. 12-month target
$631.42
Implied upside
+4.7%

Wall Street analysts covering Thermo Fisher Scientific Inc currently rate the stock a Buy on average, with a mean 12-month price target of $631.42 — +4.7% versus the last price of $603.01. Targets reflect analyst opinion, not a guarantee.

What would an investment in TMO be worth today?
Run TMO through our free historical return calculator.
Calculate TMO returns →

TMO historical returns

PeriodTotal returnAnnualized (CAGR)$1,000 grew to
1 year +22.8% +22.8% $1,228
3 years +9.3% +3.0% $1,093
5 years +10.2% +2.0% $1,102
10 years +308% +15.1% $4,077
20 years +1,528% +15.0% $16,276
Since 1985 +25,862% +14.3% $259,616

Based on monthly dividend-adjusted prices. See the full breakdown on what if you had invested in TMO.

TMO annual returns by year

2026 YTD +4.3%
2025 +11.8%
2024 -1.7%
2023 -3.4%
2022 -17.3%
2021 +43.5%
2020 +43.7%
2019 +45.5%
2018 +18.2%
2017 +35.0%

Congress trading in TMO

27 members of Congress have disclosed trading TMO — 36 purchases and 19 sales worth an estimated $1.2M. Most recent disclosure: Jul 10, 2026.

See who in Congress traded TMO →

Insider activity in TMO

TMO's own executives and directors have made 0 open-market purchases ($0) and 70 sales ($24.0M) in the last 90 days, per SEC Form 4 filings. Most recent: Aug 7, 2026.

Aug 7, 2026Holmes Joseph R. VP & Chief Accounting Officer Sell $245,620
Aug 7, 2026Casper Marc N Chairman & CEO Sell $3,464
Aug 7, 2026Casper Marc N Chairman & CEO Sell $2,317
Aug 7, 2026Casper Marc N Chairman & CEO Sell $1,159
Aug 7, 2026Casper Marc N Chairman & CEO Sell $2,323

About Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Company website ↗

TMO Key Statistics

Previous Close$605.00P/E Ratio32.6
Market Cap$222.96BPEG Ratio1.96
Revenue (TTM)$46.34BROE13.51%
Gross Margin40.99%ROA5.13%
Debt / Equity80.6Employees125,000

TMO in plain English

TMO stock: frequently asked questions

What is Thermo Fisher Scientific Inc's stock price today?

Thermo Fisher Scientific Inc (TMO) last traded at $603.01 on the NYSE. Over the past 52 weeks the stock has traded between $435.27 and $643.99.

Is TMO stock a buy or a sell?

Wall Street analysts' consensus rating on TMO is "Buy", with an average 12-month price target of $631.42 — about +4.7% versus the current price of $603.01. Analyst targets are opinions, not guarantees; always do your own research.

How much would $1,000 invested in TMO 10 years ago be worth today?

A $1,000 investment in Thermo Fisher Scientific Inc made 10 years ago would be worth about $4,077 today (dividends reinvested) — a total return of 308%, or 15.1% per year.

Does TMO pay a dividend?

Yes. Thermo Fisher Scientific Inc currently pays a dividend yielding about 0.31% per year at today's share price.

What is TMO's P/E ratio?

TMO trades at a trailing price-to-earnings ratio of 32.6, and 21.9 times expected forward earnings. The P/E ratio tells you how many dollars investors pay for each $1 of the company's annual profit.

Do members of Congress trade TMO stock?

Yes — 27 members of Congress have disclosed trades in TMO under the STOCK Act, totaling 36 purchases and 19 sales worth an estimated $1.2M.

What is Thermo Fisher Scientific Inc's ticker symbol?

Thermo Fisher Scientific Inc trades under the ticker symbol TMO on the NYSE.

Compare TMO with peers

TMO vs LLYEli Lilly and Company $1,220.28 TMO vs JNJJohnson & Johnson $260.86 TMO vs ABBVAbbVie Inc. $248.76 TMO vs UNHUnitedHealth Group Incorporated $405.59 TMO vs MRKMerck & Company, Inc. $132.92

Data last refreshed from public sources. Figures may be delayed. Not investment advice.